|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| CURRENT ASSETS: | ||||||
| Cash | ||||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | ||||||
| Prepaid expenses | ||||||
| Cash and cash equivalents | ||||||
| Marketable securities | ||||||
| Deposit assets | ||||||
| Deferred offering costs | ||||||
| Other receivables | ||||||
| Contract asset | ||||||
| Prepaid expenses and other assets | ||||||
| Total current assets | ||||||
| Deferred offering costs | ||||||
| Investments held in trust account | ||||||
| OTHER ASSETS: | ||||||
| Deposit assets, long-term | ||||||
| Equipment, net | ||||||
| Intangible assets, net | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||
| CURRENT LIABILITIES: | ||||||
| Accrued expenses | ||||||
| Simple Agreements for Future Equity | ||||||
| Accounts payable and accrued expenses | ||||||
| Deposit liabilities | ||||||
| Other current liabilities | ||||||
| Related Party | ||||||
| Total other current liabilities | ||||||
| Promissory note - related party | ||||||
| Related Party | ||||||
| Total promissory note - related party | ||||||
| Total current liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Total liabilities | ||||||
| Ordinary shares subject to possible redemption | ||||||
| Class A ordinary shares | ||||||
| Total ordinary shares subject to possible redemption | ||||||
| STOCKHOLDERS' EQUITY (DEFICIT): | ||||||
| Common stock | ||||||
| Class A ordinary shares | ||||||
| Common Class B | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total stockholders' equity (deficit) | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
Loading...